FBLN1 and arteriosclerosis: Plasma fibulin-1 was increased in patients with LV restrictive filling independent of the presence of arteriosclerosis (87±31 versus 100±26 μg/mL in patients without arteriosclerosis and 84±34 versus 123±35 μg/mL in patients with arteriosclerosis; multivariate ANOVA Prestrictive filling=0.009, Parteriosclerosis=0.94).